Inventor · disambiguated record
Mir Hashim
Also filed as: HASHIM MIR · HASHIM MIR A
38 granted patents·14 pending applications·738 citations·filing 2000–2025
98Inventor score
Top patents by PatentIndex Score
52 records- 0198US11304993B2Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteinsRANI THERAPEUTICS LLC·Filed 2018·Granted Apr 19, 2022·11 cites·14 claims
- 0298US11026998B2Shaped mass composition comprising exenatideRANI THERAPEUTICS LLC·Filed 2018·Granted Jun 8, 2021·13 cites·13 claims
- 0398US10953075B2Pharmaceutical compositions and methods for fabrication of solid masses comprising anti-interleukin antibodiesINCUBE LABS LLC·Filed 2018·Granted Mar 23, 2021·14 cites·21 claims
- 0498US9987487B2Swallowable capsule and method for stimulating incretin production within the intestinal tractINCUBE LABS LLC·Filed 2017·Granted Jun 5, 2018·45 cites·16 claims
- 0598US9643005B2Swallowable capsule and method for stimulating incretin production within the intestinal tractINCUBE LABS LLC·Filed 2016·Granted May 9, 2017·74 cites·29 claims
- 0698US9403002B2Swallowable capsule and method for stimulating incretin production within the intestinal tractINCUBE LABS LLC·Filed 2015·Granted Aug 2, 2016·81 cites·30 claims
- 0798US8958879B2Swallowable capsule and method for stimulating incretin production within the intestinal tractINCUBE LABS LLC·Filed 2014·Granted Feb 17, 2015·66 cites·30 claims
- 0898US8781591B2Swallowable capsule and method for stimulating incretin production within the intestinal tractINCUBE LABS LLC·Filed 2014·Granted Jul 15, 2014·94 cites·30 claims
- 0998US8682440B2Swallowable capsule and method for stimulating incretin production within the intestinal tractIMRAN MIR A·Filed 2010·Granted Mar 25, 2014·97 cites·34 claims
- 1097US11291709B2Pharmaceutical compositions and methods for fabrication of solid masses comprising TNF-inhibiting antibodiesRANI THERAPEUTICS LLC·Filed 2018·Granted Apr 5, 2022·10 cites·25 claims
- 1197US10603275B2Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery deviceRANI THERAPEUTICS LLC·Filed 2018·Granted Mar 31, 2020·16 cites·37 claims
- 1297US10098931B2Pharmaceutical compositions and methods for fabrication of solid masses comprising immunoglobulinsINCUBE LABS LLC·Filed 2015·Granted Oct 16, 2018·24 cites·26 claims
- 1397US10058595B2Pharmaceutical compositions and methods for fabrication of solid masses comprising TNF-inhibiting antibodiesINCUBE LABS LLC·Filed 2015·Granted Aug 28, 2018·21 cites·30 claims
- 1497US8961492B2System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalationINCUBE LABS LLC·Filed 2013·Granted Feb 24, 2015·57 cites·35 claims
- 1596US11826464B2Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery deviceRANI THERAPEUTICS LLC·Filed 2022·Granted Nov 28, 2023·3 cites·31 claims
- 1696US10220076B2Pharmaceutical compositions and methods for fabrication of solid masses comprising glucose regulating proteinsINCUBE LABS LLC·Filed 2015·Granted Mar 5, 2019·18 cites·24 claims
- 1795US11464737B2Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery deviceRANI THERAPEUTICS LLC·Filed 2020·Granted Oct 11, 2022·4 cites·51 claims
- 1895US10689460B2PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery deviceINCUBE LABS LLC·Filed 2016·Granted Jun 23, 2020·15 cites·39 claims
- 1995US10039810B2Pharmaceutical compositions and methods for fabrication of solid masses comprising anti-interleukin antibodiesINCUBE LABS LLC·Filed 2015·Granted Aug 7, 2018·13 cites·25 claims
- 2094US12201721B2Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery deviceRANI THERAPEUTICS LLC·Filed 2023·Granted Jan 21, 2025·1 cites·23 claims
- 2194US10227403B2Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteinsINCUBE LABS LLC·Filed 2016·Granted Mar 12, 2019·22 cites·52 claims
- 2294US9008765B2System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravingsIMRAN MIR·Filed 2012·Granted Apr 14, 2015·14 cites·39 claims
- 2393US11872396B2Swallowable capsule and method for stimulating incretin production within the intestinal tractINCUBE LABS LLC·Filed 2022·Granted Jan 16, 2024·1 cites·20 claims
- 2490US11548940B2Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery deviceRANI THERAPEUTICS LLC·Filed 2016·Granted Jan 10, 2023·4 cites·46 claims
- 2590US8821945B2Method for transdermal iontophoretic delivery of chelated agentsIMRAN MIR·Filed 2009·Granted Sep 2, 2014·6 cites·41 claims
- 2688US11439817B2Swallowable capsule and method for stimulating incretin production within the intestinal tractINCUBE LABS LLC·Filed 2019·Granted Sep 13, 2022·1 cites·20 claims
- 2788US2025195419A1Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery deviceRANI THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 2887US12403308B2Swallowable capsule and method for stimulating incretin production within the intestinal tractINCUBE LABS LLC·Filed 2023·Granted Sep 2, 2025·0 cites·20 claims
- 2984US12018090B2PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery deviceRANI THERAPEUTICS LLC·Filed 2020·Granted Jun 25, 2024·1 cites·36 claims
- 3083US12214019B2Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteinsRANI THERAPEUTICS LLC·Filed 2022·Granted Feb 4, 2025·0 cites·19 claims
- 3182US9764131B2System and method for biphasic transdermal iontophoretic delivery of therapeutic agentsINCUBE LABS LLC·Filed 2015·Granted Sep 19, 2017·4 cites·21 claims
- 3278US11718665B2Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteinsRANI THERAPEUTICS LLC·Filed 2019·Granted Aug 8, 2023·1 cites·36 claims
- 3378US2025241997A1Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteinsRANI THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 3474US2023372237A1Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery deviceRANI THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 3570US2023174639A1Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery deviceRANI THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 3669US9095503B2System and method for biphasic transdermal iontophreotic delivery of therapeutic agentsIMRAN MIR·Filed 2012·Granted Aug 4, 2015·1 cites·48 claims
- 3765US9402904B2Method for transdermal iontophoretic delivery of chelated agentsFE3 MEDICAL INC·Filed 2014·Granted Aug 2, 2016·0 cites·38 claims
- 3865US2023374155A1Pcsk9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery deviceRANI THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 3964US6911455B2Methods for preparing pharmaceutical formulationsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Jun 28, 2005·5 cites·32 claims
- 4064US2024050721A1Treatments for hemophilia aRANI THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 4163US9849281B2System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalationINCUBE LABS LLC·Filed 2015·Granted Dec 26, 2017·1 cites·35 claims
- 4262US2018133466A1System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalationINCUBE LABS LLC·Filed 2017·Application pending·0 cites
- 4360US2020206132A1Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery deviceINCUBE LABS LLC·Filed 2019·Application pending·0 cites
- 4455US2025236665A1Ustekinumab dosage forms and methodsRANI THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 4554US10556106B2System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravingsINCUBE LABS LLC·Filed 2017·Granted Feb 11, 2020·0 cites·22 claims
- 4654US2022118056A1Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery deviceRANI THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 4753US10780266B2System and method for biphasic transdermal iontophoretic therapeutic agentsINCUBE LABS LLC·Filed 2017·Granted Sep 22, 2020·0 cites·20 claims
- 4851US2012184894A1Patches and Methods for the Transdermal Delivery of Agents to Treat Hair LossIMRAN MIR·Filed 2012·Application pending·0 cites
- 4951US2022296868A1Intracranial delivery of medicinal solutionINCUBE LABS LLC·Filed 2020·Application pending·0 cites
- 5050US9775994B2System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravingsINCUBE LABS LLC·Filed 2015·Granted Oct 3, 2017·0 cites·10 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →